全球子宫内压力导管市场 -2023-2030
市场调查报告书
商品编码
1374783

全球子宫内压力导管市场 -2023-2030

Global Intrauterine Pressure Catheters Market -2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

多年来,全球子宫内压力导管市场经历了显着的成长和转变,影响其动态的因素有很多。分娩时将测量子宫收缩力的子宫内压力导管 (IUPC) 放入羊膜囊中。

子宫内压力导管利用导管尖端的压力感测器直接测量羊膜腔的压力,从而定量测量宫缩力。收缩率以毫米汞柱为单位进行测量,并在连接相关电缆后以图形方式显示在监视器上。

政府新产品的推出和研究,特别是在发展中经济体,将继续推动先进的液体填充导管或换能器尖端导管的使用,并推动全球子宫内压力导管市场。各自的创新产品可用于不同年龄层的人。

市场动态:驱动因素与限制因素

不断加强合作和扩张

在高投资、收入水准和基础设施发展的推动下,已开发经济体的医疗保健产业不断改善。由于怀孕率上升,一些国家对子宫内压力导管的需求量很大。不同国家之间技术进步的各种合作、收购和产品发布将是推动市场成长的关键因素。

皮尔兰市和皮尔兰经济发展公司 (PEDC) 的领导层表示,2021 年 12 月 17 日,皮尔兰下柯比区已被宣布为 Millar, Inc. 的新总部。为了将突破性的技术进步转化为拯救生命的医疗发明,Millar, Inc. 作为压力感测器产品的知名开发商和生产商,与世界製造、医疗保健和技术领域的权威机构合作。

此外,2022 年 1 月 10 日,Nuvo 推出的经 FDA 批准的远端妊娠监测平台 INVU 由 Nuvo 处方启动,由私人公司 Nuvo Group 进行行销。 Nuvo Group 与 Unified Women's Healthcare 合作,这是该国最大、最多元化的医生执业管理公司,专门为女性提供服务。

此外,越来越多地利用新技术和不同类型的子宫内压力导管进行管理。妊娠风险的上升和创新管理产品开发研究的增加将是推动子宫内压力导管市场成长的主要因素。

与子宫内压力导管相关的併发症

子宫内压力导管插入是产房和分娩室经常进行的常见技术,相关问题很少。大量研究已将子宫内压力导管的应用及其罕见的负面影响与孕产妇和新生儿发病率联繫起来。

与植入子宫内压力导管相关的一个不常见的报告后果是子宫穿孔。应小心插入子宫内压力导管,了解任何潜在后果将有助于早期诊断和选择最佳治疗方案。

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按产品类型分類的片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 不断加强合作和扩张
      • 不断进步的技术进步与发展
    • 限制
      • 与子宫内压力导管相关的併发症
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • SWOT分析
  • 专利分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按产品类型

  • 充液导管
  • 探头导管

第 8 章:最终用户

  • 医院
  • 门诊手术中心
  • 老年科

第 9 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Cardinal Health
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Koninklijke Philips NV
  • Utah Medical Products, Inc.
  • CooperSurgical Inc.
  • Laborie
  • GE HealthCare
  • Cook
  • VYAIRE
  • Millar, Inc.
  • Clinical Innovations, LLC.

第 12 章:附录

简介目录
Product Code: MD7190

Overview

The global intrauterine pressure catheters market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. An intrauterine pressure catheter (IUPC), which measures the force of uterine contractions, is put into the amniotic sac during labor.

Utilizing a pressure transducer at the catheter's tip, intrauterine pressure catheters measure the amniotic space's pressure directly, providing a quantitative measurement of the contraction's force. Contraction is measured in mm Hg and graphically shown on the monitor following connection to the relevant cable.

Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fluid-filled catheters or Transducer-tipped Catheters and boost the global intrauterine pressure catheters market. The respective innovative products are may be utilized in people with different age groups.

Market Dynamics: Drivers & Restraints

Growing collaborations and expansion

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for intrauterine pressure catheters owing to the rising pregnancies. Various collaborations, acquisitions and product launches with technological advancements among different countries will be a crucial factor driving the growth of the market.

On December 17, 2021, the Lower Kirby District of Pearland has been announced as the new headquarters for Millar, Inc., according to the leadership of the City of Pearland along with the Pearland Economic Development Corporation (PEDC). In order to transform ground-breaking technological advancements into life-saving medical inventions, Millar, Inc., an established developer and producer of pressure sensor-enabled products, collaborates with world authorities in manufacturing, healthcare, and technology.

Additionally on January 10, 2022, the FDA-cleared, remote pregnancy monitoring platform INVU which is prescription-initiated, by Nuvo is being marketed by Nuvo Group, a private company. Nuvo Group partnered with Unified Women's Healthcare, the largest, most diverse physician practice management company in the country that caters exclusively to women.

Furthermore, the rising utilization of novel technology and different types of intrauterine pressure catheters for the management purposes. Rising risks in pregnancies and increasing research for innovative management product development will be a major factor driving the growth of the intrauterine pressure catheters market.

Complications associated with intrauterine pressure catheters

Intrauterine pressure catheter insertion is a common technique carried regularly in labor and delivery units with minimal related problems. Numerous investigations have linked the application of intrauterine pressure catheters and its uncommon negative effects to maternal and newborn morbidity.

A uncommon reported consequence linked to the implantation of intrauterine pressure catheters is uterine perforation. Intrauterine pressure catheters should be inserted with care, and being aware of any potential consequences will help with an early diagnosis and the selection of the best course of action.

Segment Analysis

The global intrauterine pressure catheters market is segmented based on product type, end user and region.

Transducer-tipped Catheter segment accounted for approximately 73% of market share

A catheter tip pressure transducer is utilized for sensing the pressure in various sections of a living organism correctly and securely which comprises a pressure sensor positioned within the tip portion of a catheter. A pressure-sensitive diaphragm on which strain gauges are produced using the diffusion process is part of the pressure sensor.

The pressure sensor is attached but not firmly fastened to an insulated supporting element. Without being impacted by the thermal stresses that occur in the supporting element, the pressure sensor properly measures pressure. The uterine cavity is the intended location for this device. Many of the drawbacks of the conventional approach are eliminated with such a system.

According to the Journal of Reproductive Medicine publication, 2021, as safe as or safer than IUPCs already in use, Koala is just as functionally effective as or more so than IUPCs. The Koala also showed a number of benefits, such as a softer, shorter catheter tip that makes it easier to insert, a simpler, more compact design that makes it safer to insert and easier to operate, and precise transmission of signals to monitor.

Geographical Penetration

North America accounted for around 38% of market share in 2022

Due to the rising need for intrauterine pressure catheters in healthcare, manufacturers in North America have chances of increasing their operations. Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or medical device business establishment across the region are also contributing to the growth of intrauterine pressure catheters market share of this region.

The market in this area is growing as people become more aware of various novel innovative products such as fluid-filled catheters. The aforementioned elements attest to North America's hegemonic position in the world. An intrauterine pressure catheter is used to monitor 15-20% (600,000-800,000) of the 4 million deliveries that take place each year in the United States. This method gives the practitioner diagnostic data that is helpful for determining the pressures produced by the myometrium and monitoring the health of the fetus throughout labor and delivery.

North America continues to be a key player in the global intrauterine pressure catheters market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for intrauterine pressure catheters in the U.S. United States have been proactive in executing several initiatives or researches, stimulating intrauterine pressure catheters demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global intrauterine pressure catheters market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all over the world were disturbed by the pandemic's broad lockdowns and strict limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for intrauterine pressure catheters. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global intrauterine pressure catheters market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like transducer-tipped catheter.

Key Developments

  • On March 22, 2023, in order to create a more inclusive pregnancy care encounter from the prenatal stage through delivery and labor, Royal Philips, an international pioneer in health technological devices, and Nuvo Group, a privately held corporation marketing INVU by Nuvo, a prescription-initiated, FDA-cleared, remote pregnancy tracking platform, have joined forces. Philips and Nuvo will work together to facilitate remote fetal monitoring pilot initiatives that increase access to and adherence to recommended care in outlying locations. The first program will be in a rural Colorado community.
  • On August 16, 2022, the Australian Therapeutic Goods Administration (TGA) has given the Mikro-Cath Pressure Catheter manufacturer Millar, Inc. clearance to market it. The Mikro-Cath is a single-use pressure catheter designed for use in diagnostic and research procedures in medicine. For monitoring intra-compartmental, cardiovascular pressures and airway in people, the catheter is advised. The catheter is utilized as a short-term, restricted body contact minimally invasive device.

Competitive Landscape

The major global players in the market include: Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Laborie, GE HealthCare, Cook, VYAIRE, Millar, Inc. and Clinical Innovations, LLC among others.

Why Purchase the Report?

  • To visualize the global intrauterine pressure catheters market segmentation based on product type, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of intrauterine pressure catheters market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global intrauterine pressure catheters market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing collaborations and expansion
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with intrauterine pressure catheters
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. SWOT Analysis
  • 5.6. Patent Analysis
  • 5.7. Russia-Ukraine War Impact Analysis
  • 5.8. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Fluid-filled Catheters*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Transducer-tipped Catheter

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Geriatric

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cardinal Health*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Koninklijke Philips N.V.
  • 11.3. Utah Medical Products, Inc.
  • 11.4. CooperSurgical Inc.
  • 11.5. Laborie
  • 11.6. GE HealthCare
  • 11.7. Cook
  • 11.8. VYAIRE
  • 11.9. Millar, Inc.
  • 11.10. Clinical Innovations, LLC.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us